Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Subías

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Thrombosis and Hemostasis|May 7, 2014
Genetics of atypical hemolytic uremic syndrome (aHUS)Santiago Rodríguez de Córdoba, Marta Subías Hidalgo, Sheila Pinto, et al.
FEBS Letters|October 23, 2010
A free radical-generating system regulates APP metabolism/processingMaría Recuero, Teresa Muñoz, Jesús Aldudo, et al.
Molecular Immunology|March 4, 2017
Ionic tethering contributes to the conformational stability and function of complement C3bAndrés López-Perrote, Reed E S Harrison, Marta Subías, et al.
The FEBS Journal|August 8, 2015
Structural insights on complement activationMartín Alcorlo, Andrés López-Perrote, Sandra Delgado, et al.
European Journal of Immunology|January 14, 2017
Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applicationsMarta Subías Hidalgo, Hugo Yébenes, César Rodríguez-Gallego, et al.
Frontiers in Immunology|November 19, 2019
Blocking Complement Factor B Activation Reduces Renal Injury and Inflammation in a Rat Brain Death ModelNeeltina M Jager, Judith E van Zanden, Marta Subías, et al.
Blood|March 2, 2021
Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseasesHéctor Martin Merinero, Marta Subías, Amaia Pereda, et al.
Immunobiology|September 21, 2016
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatmentMarta Subías Hidalgo, Hector Martin Merinero, Alicia López, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease modelsMarta Subías, Agustín Tortajada, Sara Gastoldi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Thrombosis and Hemostasis|May 7, 2014
Genetics of atypical hemolytic uremic syndrome (aHUS)Santiago Rodríguez de Córdoba, Marta Subías Hidalgo, Sheila Pinto, et al.
FEBS Letters|October 23, 2010
A free radical-generating system regulates APP metabolism/processingMaría Recuero, Teresa Muñoz, Jesús Aldudo, et al.
Molecular Immunology|March 4, 2017
Ionic tethering contributes to the conformational stability and function of complement C3bAndrés López-Perrote, Reed E S Harrison, Marta Subías, et al.
The FEBS Journal|August 8, 2015
Structural insights on complement activationMartín Alcorlo, Andrés López-Perrote, Sandra Delgado, et al.
European Journal of Immunology|January 14, 2017
Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applicationsMarta Subías Hidalgo, Hugo Yébenes, César Rodríguez-Gallego, et al.
Frontiers in Immunology|November 19, 2019
Blocking Complement Factor B Activation Reduces Renal Injury and Inflammation in a Rat Brain Death ModelNeeltina M Jager, Judith E van Zanden, Marta Subías, et al.
Blood|March 2, 2021
Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseasesHéctor Martin Merinero, Marta Subías, Amaia Pereda, et al.
Immunobiology|September 21, 2016
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatmentMarta Subías Hidalgo, Hector Martin Merinero, Alicia López, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease modelsMarta Subías, Agustín Tortajada, Sara Gastoldi, et al.
Pageof 1